Skip to main content
COCH
NASDAQ Industrial Applications And Services

Envoy Medical Completes Pivotal Trial Enrollment, Reports Positive Early Data, and Secures $30M Capital

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.648
Mkt Cap
$49.627M
52W Low
$0.363
52W High
$1.91
52W Position info
79% above low
Off High info
66% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

COCH sits 79% above its 52-week low of $0.363 on light trading volume (0.2× avg).

Summary

Envoy Medical announced the completion of enrollment in its pivotal clinical trial for the Acclaim cochlear implant and reported promising early clinical data, alongside a strengthened cash position from a recent $30 million capital raise.


Key Events · Product Development and Regulatory · COCH

  • Pivotal Trial Enrollment Completed

    Envoy Medical successfully completed enrollment of 56 patients in its U.S. pivotal clinical trial for the Acclaim® cochlear implant on March 11, 2026, a critical step towards FDA Premarket Approval (PMA).

  • Positive Early Clinical Data Reported

    Interim six-month data from the first 10 patients showed no serious adverse events and significant improvement in word recognition scores (from 15.2% to 39.2%), along with improvements in quality-of-life and tinnitus scores.

  • Strengthened Cash Position

    The company reported a cash balance of approximately $25.25 million as of March 31, 2026, a substantial increase from $3.74 million at year-end 2025, following a $30 million capital raise.

  • Advancing Towards Commercialization

    All 56 pivotal trial patients have been activated, and the first three patients have completed their 12-month endpoint visits, keeping the company on track for PMA submission.


Analysis · COCH · Industrial Applications And Services

This filing is critical as Envoy Medical, a company previously facing a 'going concern' warning, has achieved major milestones. The completion of enrollment in its pivotal clinical trial for the Acclaim cochlear implant and the presentation of positive interim 6-month data significantly de-risk its path to FDA approval and potential commercialization. Furthermore, the $30 million capital raise has substantially improved its cash position to $25.25 million, providing crucial runway to fund operations and advance the clinical program. This combination of clinical progress and financial stability is a strong positive for the company's future.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, COCH was trading at $0.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $49.6M. The 52-week trading range was $0.36 to $1.91. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COCH - Latest Insights

COCH
Nov 05, 2026, 1:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $7.11 info
Change: +$0.065 (+0.92%) info
Market Cap: $54.95M info
COCH
Nov 05, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.11 info
Change: -$0.0100 (-0.14%) info
Market Cap: $54.95M info
COCH
Aug 31, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 19, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.740
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.705
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info